Cut, Keep, or Cash In: The Pharmaceutical Patent Decision Matrix That Separates Winning Portfolios from Expensive Archives
Pharma patent strategy is entering a new era: stop treating every patent like a winner. Start treating it like a portfolio.
If you’re building a pharmaceutical IP strategy today, you’re probably still asking the same question—“Do we have a patent?”
B…
